 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
4/10/23 Rubius Therapeutics, Inc. 15-12G 4/10/23 1:12K Toppan Merrill/FA
4/10/23 FMR LLC SC 13G/A 1:8K Rubius Therapeutics, Inc.
4/6/23 Rubius Therapeutics, Inc. 8-K:5,9 4/6/23 10:186K Toppan Merrill/FA
3/28/23 Rubius Therapeutics, Inc. 25 3/28/23 1:12K Toppan Merrill/FA
3/9/23 Rubius Therapeutics, Inc. DEF 14A 4/6/23 1:2M Toppan Merrill/FA
3/3/23 Rubius Therapeutics, Inc. 8-K:3,5 2/27/23 10:192K Toppan Merrill/FA
3/3/23 Baillie Gifford & Co. SC 13G/A 1:10K Rubius Therapeutics, Inc.
3/2/23 Rubius Therapeutics, Inc. PRER14A 1:2.3M Toppan Merrill/FA
2/27/23 Appelhans Dannielle 4 Officer² 1:5K Rubius Therapeutics, Inc. Toppan Merrill/FA
2/27/23 Rubius Therapeutics, Inc. PRE 14A 2/27/23 1:465K Toppan Merrill/FA
2/27/23 Rubius Therapeutics, Inc. 10-K 12/31/22 77:7.2M
2/27/23 Rubius Therapeutics, Inc. S-8 POS 2/27/23 1:28K Toppan Merrill/FA
2/27/23 Rubius Therapeutics, Inc. S-8 POS 2/27/23 1:28K Toppan Merrill/FA
2/27/23 Rubius Therapeutics, Inc. S-8 POS 2/27/23 1:28K Toppan Merrill/FA
2/27/23 Rubius Therapeutics, Inc. S-8 POS 2/27/23 1:28K Toppan Merrill/FA
2/27/23 Rubius Therapeutics, Inc. S-8 POS 2/27/23 1:28K Toppan Merrill/FA
2/22/23 Rubius Therapeutics, Inc. RW 1:8K Toppan Merrill/FA
2/22/23 Rubius Therapeutics, Inc. 8-K:8,9 2/20/23 11:225K Toppan Merrill/FA
2/14/23 Flagship VentureLabs IV, LLC SC 13G/A 1:157K Rubius Therapeutics, Inc. Donnelley … Solutions/FA
Flagship V Venturelabs RX Fund, L.P.³
Flagship Ventures Fund IV General Partner LLC³
Flagship Ventures Fund IV, L.P.³
Flagship Ventures Fund IV-RX, L.P.³
Flagship Ventures Fund V General Partner LLC³
Flagship Ventures Fund V, L.P.³
Flagship Ventures Opportunities Fund I General Partner LLC³
Flagship Ventures Opportunities Fund I, L.P.³
Noubar B. Afeyan, Ph.D.³
2/9/23 FMR LLC SC 13G/A 1:8K Rubius Therapeutics, Inc.
| ____________ | | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-K | Annual Report — Form 10-K. | | 15-12G | Certification of a Termination of Registration of a Class of Securities — Form 15. | | 25 | Notice by an Issuer of the Removal from Listing and Registration on a Securities Exchange of Matured, Redeemed or Retired Securities — Form 25. | | DEF 14A | Definitive Proxy Statement — Schedule 14A. | | PRE 14A | Preliminary Proxy Statement — Schedule 14A. | | PRER14A | Preliminary Revised Proxy Soliciting Material — Schedule 14A. | | RW | Registration Withdrawal Request. | | S-8 POS | Post-Effective Amendment of a Form S-8 Registration. | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. | | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|
